MediPharm Labs
(OTC) MEDIF
MediPharm Labs Financials at a Glance
Market Cap
$20.24M
Revenue (TTM)
$46.10M
Net Income (TTM)
$8.03M
EPS (TTM)
$-0.01
P/E Ratio
-3.46
Dividend
$0.00
Beta (Volatility)
0.69 (Low)
Dividend
$0.00
Beta (Volatility)
0.69 (Low)
Price
$0.05
Volume
33,704
Open
$0.05
Price
$0.05
Volume
33,704
Open
$0.05
Previous Close
$0.05
Daily Range
$0.04 - $0.05
52-Week Range
$0.04 - $0.08
Dividend
$0.00
Beta (Volatility)
0.69 (Low)
Price
$0.05
Volume
33,704
Open
$0.05
Previous Close
$0.05
Daily Range
$0.04 - $0.05
52-Week Range
$0.04 - $0.08
MEDIF News
3 Pot Stocks to Stay Miles Away From
MEDIF: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout MediPharm Labs
Industry
Pharmaceuticals
Sector
Health CareEmployees
127
CEO
David A. Pidduck, EMBA
Website
www.medipharmlabs.comHeadquarters
Barrie, ON L4N 2L1, CA
MEDIF Financials
Key Financial Metrics (TTM)
Gross Margin
29%
Operating Margin
-18%
Net Income Margin
-17%
Return on Equity
-21%
Return on Capital
-22%
Return on Assets
-17%
Earnings Yield
-28.90%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$20.24M
Shares Outstanding
420.75M
Volume
33.70K
Short Interest
0.00%
Avg. Volume
98.88K
Financials (TTM)
Gross Profit
$12.80M
Operating Income
$10.81M
EBITDA
$7.52M
Operating Cash Flow
$4.86M
Capital Expenditure
$154.00K
Free Cash Flow
$5.01M
Cash & ST Invst.
$11.88M
Total Debt
$388.00K
MediPharm Labs Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$11.45M
+16.8%
Gross Profit
$2.56M
-17.9%
Gross Margin
22.38%
N/A
Market Cap
$20.24M
N/A
Market Cap/Employee
$121.92K
N/A
Employees
166
N/A
Net Income
$2.14M
+22.8%
EBITDA
$1.71M
+15.6%
Quarterly Fundamentals
Net Cash
$10.16M
-18.3%
Accounts Receivable
$7.72M
+15.4%
Inventory
$8.10M
-11.9%
Long Term Debt
$0.00
-100.0%
Short Term Debt
$423.00K
-31.7%
Return on Assets
-17.22%
N/A
Return on Invested Capital
-21.96%
N/A
Free Cash Flow
$174.00K
+75.0%
Operating Cash Flow
$158.00K
+76.1%